Scientific Programme
![]() | Download the Scientific Programme in PDF format |
08.30 |
REGISTRATION AND INTRODUCTION |
|
9.00 - 10.00 |
Personalised medicine: challenges and opportunities |
M Pirmohamed* Liverpool UK |
|
Companion biomarkers in colorectal cancer |
M Seymour* Leeds UK |
10.00 - 11.00 |
Blood borne biomarkers of cell death in early clinical trials |
C Dive* Manchester UK |
|
Protein profiling of signalling pathways from FFPE sections |
KF Becker* Munich |
11.00 - 11.30 |
Coffee/refreshments |
|
11.30 - 13.15 |
Second generation sequencing of human cancers Circulating Tumour DNA Molecular profiling of tumours: what have we gained? |
N Hall* Liverpool XiaoY Zhong* Basel PG Johnston Belfast |
13.15 - 14.00 |
LUNCH |
|
14.00 - 15.00
|
FDG PET as a predictor of response in clinical trials Integrating histopathology, molecular biomarkers and imaging |
D Slosman* Geneva D Treanor* Leeds |
15.15 - 15.30 |
Coffee/refreshments |
|
15.30 - 16.30 |
Circulating Tumour Cells Summary |
B Brandt* Hamburg R Wooster*, GSK, Philadelphia |
| *speakers confirmed | ||













